Clinical trial
A Global, Non-interventional Study to Prospectively Evaluate Bleeding Episodes and Treatment Use in Patients with Hemophilia
NCT05605678 is registered in ClinicalTrials.gov with ApcinteX Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Global, Non-interventional Study to Prospectively Evaluate Bleeding Episodes and Treatment Use in Patients with Hemophilia
- Lead sponsor
- ApcinteX Ltd
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 9, 2022
- Completion date
- November 29, 2024
- Enrollment
- 108 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.